KELLY WHALEN: Open Payments
NPI 1811502578 · GASTONIA, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$405 in 13 payments from 7 companies in 2025. Trend: 2023 $120 · 2024 $0 · 2025 $405
Food & beverage: $405
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $132 |
| United Therapeutics Corporation | 1 | $88 |
| GlaxoSmithKline, LLC. | 2 | $43 |
| Viatris Specialty LLC | 2 | $42 |
| Actelion Pharmaceuticals US, Inc. | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $36 |
| Grifols USA, LLC | 1 | $25 |
Products named: TYVASO, FASENRA, YUPELRI, OPSYNVI, DUPIXENT, NUCALA, Prolastin-C Liquid, TEZSPIRE.
Industry payments across NC — which companies pay providers there.
